These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3003910)

  • 21. [Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein].
    Behr J; König G; Meurer M; Krieg T
    Pneumologie; 1990 Jun; 44(6):822-5. PubMed ID: 2381889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.
    Seelig HP; Schröter H; Ehrfeld H; Renz M
    J Immunol Methods; 1993 Oct; 165(2):241-52. PubMed ID: 8228274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cross-reactive idiotype in scleroderma.
    Vázquez-Abad D; Tian L; Zanetti M; Rothfield NF
    Clin Exp Immunol; 1997 Jun; 108(3):420-7. PubMed ID: 9182886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-Scl-70 antibody (anti-topoisomerase I antibody)].
    Kuwana M; Mimori T
    Nihon Rinsho; 1999 Nov; 57 Suppl():425-7. PubMed ID: 10635873
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of topoisomerase I by antibodies in sera from scleroderma patients.
    Samuels DS; Tojo T; Homma M; Shimizu N
    FEBS Lett; 1986 Dec; 209(2):231-4. PubMed ID: 2431927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scl-86, a marker antigen for diffuse scleroderma.
    van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
    J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies in scleroderma.
    Pollard KM; Reimer G; Tan EM
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
    Hénault J; Robitaille G; Senécal JL; Raymond Y
    Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.
    Whyte J; Earnshaw WC; Champoux JJ; Parker LH; Stewart L; Hall ND; McHugh NJ
    Clin Exp Immunol; 1995 May; 100(2):214-8. PubMed ID: 7743657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self reactive repertoire of tight skin mouse: immunochemical and molecular characterization of anti-topoisomerase I autoantibodies.
    Muryoi T; Kasturi KN; Kafina MJ; Saitoh Y; Usuba O; Perlish JS; Fleischmajer R; Bona CA
    Autoimmunity; 1991; 9(2):109-17. PubMed ID: 1718459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
    Brouwer R; Vree Egberts WT; Hengstman GJ; Raijmakers R; van Engelen BG; Seelig HP; Renz M; Mierau R; Genth E; Pruijn GJ; van Venrooij WJ
    Arthritis Res; 2002; 4(2):134-8. PubMed ID: 11879549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis.
    Maul GG; Jimenez SA; Riggs E; Ziemnicka-Kotula D
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8492-6. PubMed ID: 2479024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis.
    McNeilage LJ; Whittingham S; McHugh N; Barnett AJ
    J Immunol; 1986 Oct; 137(8):2541-7. PubMed ID: 3531335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
    Genth E; Mierau R
    Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.